Abbvie (ABBV) Holder Wendell David Associates Has Trimmed Position by $678,240; Automatic Data Processing In (ADP) Market Valuation Declined While Atlanta Capital Group Has Decreased Stake

May 23, 2018 - By Dolores Ford

AbbVie Inc. (NYSE:ABBV) Logo

Atlanta Capital Group decreased its stake in Automatic Data Processing In (ADP) by 19.56% based on its latest 2017Q4 regulatory filing with the SEC. Atlanta Capital Group sold 2,940 shares as the company’s stock declined 3.95% with the market. The institutional investor held 12,093 shares of the technology company at the end of 2017Q4, valued at $1.42 million, down from 15,033 at the end of the previous reported quarter. Atlanta Capital Group who had been investing in Automatic Data Processing In for a number of months, seems to be less bullish one the $56.16B market cap company. The stock decreased 0.69% or $0.8901 during the last trading session, reaching $127.4899. About 21,441 shares traded. Automatic Data Processing, Inc. (NASDAQ:ADP) has risen 9.09% since May 23, 2017 and is uptrending. It has underperformed by 2.46% the S&P500.

Wendell David Associates Inc decreased its stake in Abbvie (ABBV) by 5.88% based on its latest 2017Q4 regulatory filing with the SEC. Wendell David Associates Inc sold 7,065 shares as the company’s stock declined 6.31% with the market. The institutional investor held 113,028 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $10.93 million, down from 120,093 at the end of the previous reported quarter. Wendell David Associates Inc who had been investing in Abbvie for a number of months, seems to be less bullish one the $168.57B market cap company. It closed at $106.23 lastly. It is down 39.20% since May 23, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Analysts await Automatic Data Processing, Inc. (NASDAQ:ADP) to report earnings on July, 26. They expect $0.89 EPS, up 36.92% or $0.24 from last year’s $0.65 per share. ADP’s profit will be $392.06 million for 35.81 P/E if the $0.89 EPS becomes a reality. After $1.52 actual EPS reported by Automatic Data Processing, Inc. for the previous quarter, Wall Street now forecasts -41.45% negative EPS growth.

Since December 31, 2017, it had 0 buys, and 27 insider sales for $43.50 million activity. 592 shares were sold by Black Maria, worth $72,129. Sackman Stuart sold $10,875 worth of stock. O’Brien Dermot J had sold 25,115 shares worth $2.91M on Monday, January 1. The insider Weinstein Donald sold $263,968. Shares for $3.53M were sold by Bonarti Michael A. Shares for $2.42 million were sold by Politi Douglas W.

Among 19 analysts covering Automatic Data (NASDAQ:ADP), 5 have Buy rating, 2 Sell and 12 Hold. Therefore 26% are positive. Automatic Data had 64 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, November 6 by RBC Capital Markets. As per Friday, January 12, the company rating was maintained by Citigroup. The stock has “Buy” rating by Goldman Sachs on Friday, December 16. The rating was maintained by BMO Capital Markets on Monday, January 22 with “Hold”. Morgan Stanley downgraded the stock to “Underweight” rating in Thursday, August 3 report. Robert W. Baird downgraded Automatic Data Processing, Inc. (NASDAQ:ADP) rating on Friday, July 29. Robert W. Baird has “Neutral” rating and $94 target. Morgan Stanley maintained the shares of ADP in report on Thursday, May 3 with “Equal-Weight” rating. The firm earned “Buy” rating on Friday, May 4 by Bank of America. The stock of Automatic Data Processing, Inc. (NASDAQ:ADP) earned “Neutral” rating by JP Morgan on Friday, August 14. On Tuesday, November 3 the stock rating was maintained by Argus Research with “Buy”.

Atlanta Capital Group, which manages about $1.02 billion and $676.09 million US Long portfolio, upped its stake in Blackstone Group LP (NYSE:BX) by 10,065 shares to 28,672 shares, valued at $918,000 in 2017Q4, according to the filing. It also increased its holding in Abbvie Inc (NYSE:ABBV) by 5,272 shares in the quarter, for a total of 33,629 shares, and has risen its stake in Adobe Sys Inc (NASDAQ:ADBE).

Investors sentiment increased to 0.8 in Q4 2017. Its up 0.12, from 0.68 in 2017Q3. It increased, as 50 investors sold ADP shares while 442 reduced holdings. 113 funds opened positions while 282 raised stakes. 338.15 million shares or 1.20% less from 342.26 million shares in 2017Q3 were reported. Cannell Peter B Com holds 0.36% or 89,636 shares. Louisiana State Employees Retirement System reported 26,800 shares. M&R Cap accumulated 4,410 shares. Segall Bryant Hamill Limited Company holds 1,790 shares. Abner Herrman And Brock Limited Liability reported 105,877 shares. Verition Fund Mgmt Limited holds 3,833 shares. Klingenstein Fields And Co Limited Liability holds 4,436 shares or 0.02% of its portfolio. Estabrook Cap Mgmt has 0.02% invested in Automatic Data Processing, Inc. (NASDAQ:ADP) for 1,160 shares. Germany-based Meag Munich Ergo Kapitalanlagegesellschaft Mbh has invested 0.1% in Automatic Data Processing, Inc. (NASDAQ:ADP). Commerzbank Aktiengesellschaft Fi has 0.02% invested in Automatic Data Processing, Inc. (NASDAQ:ADP) for 12,490 shares. Whalerock Point Prtnrs Lc has invested 0.85% in Automatic Data Processing, Inc. (NASDAQ:ADP). Lifeplan Fincl Grp holds 0.17% or 2,384 shares. Caprock Grp holds 9,740 shares or 0.22% of its portfolio. Tokio Marine Asset Limited reported 19,624 shares. Nuveen Asset Mngmt Ltd Co has invested 0.01% in Automatic Data Processing, Inc. (NASDAQ:ADP).

More notable recent Automatic Data Processing, Inc. (NASDAQ:ADP) news were published by: Globenewswire.com which released: “ADP Reports Third Quarter Fiscal 2018 Results” on May 02, 2018, also Seekingalpha.com with their article: “ADP +3.2% on Q3 beat, raised full-year profit expectations” published on May 02, 2018, Nasdaq.com published: “Recent Analysis Shows Shutterfly, Gulfport Energy, Automatic Data Processing, Group 1 Automotive, Red Robin …” on May 16, 2018. More interesting news about Automatic Data Processing, Inc. (NASDAQ:ADP) were released by: Streetinsider.com and their article: “Sachem Head Capital Enters ADP (ADP), PagSeguro Digita (PAGS), WorldPay (WP) (more…) – 13F” published on May 15, 2018 as well as Prnewswire.com‘s news article titled: “The Future of Pay is Here! New ADP Innovation Helps Employers Tailor Payments to the Preferences of All Employees” with publication date: May 14, 2018.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $3.13 billion for 13.48 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Tuesday, January 16. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) rating on Thursday, November 16. BMO Capital Markets has “Market Perform” rating and $84 target. The rating was downgraded by Credit Suisse to “Neutral” on Monday, October 31. Citigroup downgraded AbbVie Inc. (NYSE:ABBV) on Monday, November 28 to “Neutral” rating. The rating was maintained by Piper Jaffray with “Buy” on Friday, September 15. Piper Jaffray maintained AbbVie Inc. (NYSE:ABBV) rating on Thursday, September 28. Piper Jaffray has “Buy” rating and $102.0 target. As per Friday, April 27, the company rating was maintained by Credit Suisse. The rating was maintained by SunTrust with “Buy” on Monday, October 16. BMO Capital Markets maintained the shares of ABBV in report on Friday, March 23 with “Underperform” rating. Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, March 23. Jefferies has “Buy” rating and $12500 target.

Since December 14, 2017, it had 0 insider purchases, and 11 selling transactions for $47.70 million activity. 4,294 AbbVie Inc. (NYSE:ABBV) shares with value of $512,853 were sold by Michael Robert A.. On Wednesday, February 28 the insider CHASE WILLIAM J sold $8.31M. RICHMOND TIMOTHY J. had sold 18,129 shares worth $2.15 million on Wednesday, February 28. The insider ALBAN CARLOS sold 83,574 shares worth $9.57 million. SEVERINO MICHAEL also sold $311,684 worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28. On Thursday, December 14 Schumacher Laura J sold $14.07M worth of AbbVie Inc. (NYSE:ABBV) or 145,510 shares.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It worsened, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Oakworth Incorporated reported 0.21% stake. Waldron Limited Partnership owns 5,540 shares. Legacy Prns invested in 2.74% or 57,324 shares. Kistler stated it has 7,326 shares. Numeric Investors Limited Com invested in 0.66% or 933,000 shares. Jacobs Company Ca invested 1.27% in AbbVie Inc. (NYSE:ABBV). Sigma Invest Counselors stated it has 0.59% of its portfolio in AbbVie Inc. (NYSE:ABBV). Estabrook Capital holds 0.3% or 20,409 shares. Invesco has 0.1% invested in AbbVie Inc. (NYSE:ABBV). Stonebridge Advisors Ltd Llc reported 1.92% in AbbVie Inc. (NYSE:ABBV). Trust Of Virginia Va owns 0.28% invested in AbbVie Inc. (NYSE:ABBV) for 20,437 shares. 5,731 are held by Fragasso. Winch Advisory Serv Lc holds 0% or 83 shares. Ghp Advisors owns 5,970 shares or 0.08% of their US portfolio. Harris Assocs LP reported 42,100 shares stake.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Biotechs perk up ahead of ASCO abstract drop” on May 16, 2018, also Nasdaq.com with their article: “Better Buy: AbbVie Inc. vs. Pfizer Inc.” published on May 23, 2018, Seekingalpha.com published: “AbbVie Is Still A One-Trick Pony” on April 26, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Streetinsider.com and their article: “Abbvie (ABBV) PT Lowered to $78 at BMO Capital” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie: Can Mylan Pull Off A Humira Biosimilar?” with publication date: May 01, 2018.

Automatic Data Processing, Inc. (NASDAQ:ADP) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>